INDEPENDENT THINKING. TRACEABLE EVIDENCE.Research edition · 29 October 2026
Modern DosingTHE PRACTITIONER’S PERSPECTIVEA clearer view of
the peptide economy ↗
The provider file / Dossier 275
RESEARCH DOSSIER / NOT AN ENDORSEMENT

Yazen

A dated business research record, with the original field-level evidence labels kept intact.

Source snapshot: 2026-10-29. “Verified” below is the source dataset author’s label—not an independent license, safety, quality or clinical audit by Modern Dosing. These pages are excluded from search indexing until reviewed.
Positioning & service claimsverified

'Medical weight loss with tailored advice' (SE site). Yazen model: GLP-1 medication plus doctor, YazenCoach, dietitian, psychologist and personal trainer; claims patients lose on average 20% of body weight in the first year.

Audienceread

Patients with overweight/obesity in Sweden and 7 other European countries seeking medically supervised GLP-1 care.

Pricing & termspartial

SEK pricing not captured from the Swedish site in this pass; program bundles medical team follow-up in one subscription.

Clinical relationshipsverified

Registered Swedish healthcare provider under the Health and Medical Care Act; proprietary app and EMR registered with IVO. Employed doctors with special interest in obesity.

Pharmacy & fulfillmentnot_found

GLP-1 prescriptions dispensed via Swedish/EU pharmacies; not named on reviewed pages.

    Advertising snapshotpartial

    Google: '1 ad' header with 4 Yazen Health AB cards (20 Oct 2026). Meta keyword ~3 results. LinkedIn: ~19 genuine Yazen Health ads, mostly Swedish recruitment/employer brand. See dated channel evidence.

    Founding yearnot_found

    Not established in this pass.

      Foundersnot_found

      Not established in this pass.

        Location & entity contextverified

        Sweden (Yazen Health AB); operates in 8 European countries per discovery sources.

        Search visibility samplenot_found

        Not assessed in this pass.

          THE MODERN DOSING WEEKLY

          The peptide news
          that changes your week.

          Evidence-backed developments. The moves that matter. What each means for your practice or business—in one weekly email.